European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care.
Jerry P Nolan, Claudio Sandroni, Bernd W Böttiger...
https://pubmed.ncbi.nlm.nih.gov/33765189/Actively Recruiting
Led by University of Pecs · Updated on 2026-09-29
477
Participants Needed
4
Research Sites
26 weeks
Total Duration
Researchers are studying how specific proteins called neurobiomarkers behave in the very first minutes and hours after acute brain injuries like traumatic brain injury TBI and cardiac arrest CA. These conditions cause brain cells to release proteins into the blood, which might help doctors assess injury severity, guide treatment, and predict outcomes. The study focuses on measuring these markers during the hyperacute phase, a time that is not well understood, especially in emergency and prehospital settings. Participants include three groups those with severe TBI or polytrauma treated before hospital arrival, cardiac arrest patients treated before hospital arrival, and severe TBI patients enrolled upon emergency department admission. Blood samples are taken multiple times starting in the prehospital phase and continuing up to 24 hours after hospital admission. No experimental treatments are given all participants receive standard emergency and intensive care. During the study, blood samples are analyzed for various neurobiomarkers, microRNAs, and metabolites using specialized laboratory methods. Researchers track outcomes like mortality up to 30 days and neurological status to understand how biomarker levels relate to injury severity and recovery. The study is conducted at multiple centers including emergency departments, intensive care units, and ambulance services, with a planned enrollment of 477 participants and follow-up extending to 12 months for long-term outcomes.
CONDITIONS
Critical Hyperacute Assessment Research On Neurobiomarker Kinetics in Acute Brain Injury
E
Endre Czeiter, MD, PhD
Á
Ábel Papp, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Pecs
Lead Sponsor
Örebro University, Sweden
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 24 hours
Participants have serial blood samples collected starting in the prehospital setting or emergency department and continuing up to 24 hours after hospital admission. No experimental treatments are given; standard emergency and intensive care are provided.
Multiple blood sampling time points during prehospital and hospital care
Duration - Up to 12 months
Researchers assess neurological status and mortality outcomes up to 30 days and functional outcomes up to 12 months after injury or cardiac arrest.
Periodic follow-up assessments
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Jerry P Nolan, Claudio Sandroni, Bernd W Böttiger...
https://pubmed.ncbi.nlm.nih.gov/33765189/Endre Czeiter, Krisztina Amrein, Benjamin Y Gravesteijn...
https://pubmed.ncbi.nlm.nih.gov/32464528/Jeffrey J Bazarian, Peter Biberthaler, Robert D Welch...
https://pubmed.ncbi.nlm.nih.gov/30054151/Stefania Mondello, Abayomi Sorinola, Endre Czeiter...
https://pubmed.ncbi.nlm.nih.gov/29020853/Ilias Thomas, Alex M Dickens, Jussi P Posti...
https://pubmed.ncbi.nlm.nih.gov/35538079/Marion Moseby-Knappe, Niklas Mattsson-Carlgren, Pascal Stammet...
https://pubmed.ncbi.nlm.nih.gov/34417831/Patrik Gilje, Olof Gidlöf, Malin Rundgren...
https://pubmed.ncbi.nlm.nih.gov/24588965/Iftakher Hossain, Niklas Marklund, Endre Czeiter...
https://pubmed.ncbi.nlm.nih.gov/38510630/Stefania Mondello, Krisztina Amrein, Endre Czeiter...
https://pubmed.ncbi.nlm.nih.gov/40432557/Andrew I R Maas, David K Menon, P David Adelson...
https://pubmed.ncbi.nlm.nih.gov/29122524/University of Pecs
Lead Sponsor
Örebro University, Sweden
Collaborating Sponsor